Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Laryngeal cancer
Stage/Subtype:  stage II laryngeal cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-14 of 14 for your search:
Start Over
Vaccine Therapy and Cyclophosphamide in Treating Patients with Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J09100, NCI-2010-01868, CIR00005394, NA_00031401, NCT01088789
Docetaxel, Cisplatin, and Cetuximab in Treating Patients With Metastatic or Relapsed Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 16 and over
Trial IDs: ENT0033, NCI-2011-03271, 22329, SU-08222011-8290, NCT01437449
Azacitidine in Measuring Tumor Response in Patients with HPV Positive or Negative Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 1404013771, NCI-2015-01437, 200 FR. 4 (2012-1), NCT02178072
Surgery with or without Stereotactic Body Radiotherapy in Treating Patients with Previously-Irradiated Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-151, NCI-2015-01424, NCT02516969
IMRT in Treating Patients with Laryngeal Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: RT-083, NCI-2015-02223, NCT02633540
Afatinib Dimaleate and Radiation Therapy with or without Docetaxel in Treating Patients with Head and Neck Cancer Previously Treated with Surgery
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 12-267, NCI-2013-00626, NCT01783587
Ketogenic Diet during Chemotherapy and Radiation Therapy in Treating Patients with Stage II-IVB Squamous Cell Carcinoma of the Oropharynx, Larynx, or Hypopharynx
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201309759, NCI-2014-00834, NCT01975766
Stereotactic Body Radiation Therapy in Treating Patients with Early-Stage Glottic Laryngeal Cancer
Status: Active
Phase: Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: STU 062013-052, NCI-2015-01668, NCT01984502
Biomarker Response to Cetuximab and VTX-2337 in Treating Patients with Stage II-IVA Head and Neck Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 14-002, NCI-2014-01430, UPCI #14-002, VRXP-A106, NCT02124850
Image-Guided Hypofractionated Intensity Modulated Radiation Therapy and Cisplatin in Treating Patients with Locally Advanced Squamous Cell Carcinoma of the Oropharynx, Hypopharynx, or Larynx
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: STU 112013-007, NCI-2014-02123, 8843, NCI-2014-02009, NCT02201355
A Window of Opportunity Study of KTN3379 in Surgically Resectable Head and Neck Cancer Patients
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: KTN3379-CL-002, NCI-2015-01572, NCT02473731
Transoral Robotic Surgery in Treating Patients with Benign or Malignant Tumors of the Head and Neck
Status: Active
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: OSU-07061, NCI-2011-03122, 07061, NCT01473784
Transoral Robotic Surgery in Treating Patients with Oropharyngeal or Supraglottic Squamous Cell Carcinoma
Status: Active
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: SCCA-TORS-2012, NCI-2013-01936, 16376, NCT01819480
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients with Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 229812, NCI-2013-01198, NCT01896778
Start Over